Anti-diabetic drugs and weight loss in patients with type 2 diabetes
Introduction Obesity is frequently a comorbidity of type 2 diabetes. Even modest weight loss
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
Anti-diabetic drugs and weight loss in patients with type 2 diabetes
E Lazzaroni, M Ben Nasr, C Loretelli, I Pastore… - PHARMACOLOGICAL …, 2021 - air.unimi.it
Introduction: Obesity is frequently a comorbidity of type 2 diabetes. Even modest weight loss
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
Anti-diabetic drugs and weight loss in patients with type 2 diabetes
E Lazzaroni, MB Nasr, C Loretelli… - Pharmacological …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Obesity is frequently a comorbidity of type 2 diabetes. Even modest weight loss
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
[PDF][PDF] Anti-diabetic drugs and weight loss in patients with type 2 diabetes
E Lazzaroni, MB Nasr, C Loretelli, I Pastore… - Pharmacological …, 2021 - casadiabete.it
Introduction: Obesity is frequently a comorbidity of type 2 diabetes. Even modest weight loss
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
Anti-diabetic drugs and weight loss in patients with type 2 diabetes
E Lazzaroni, MB Nasr, C Loretelli, I Pastore… - Pharmacological …, 2021 - Elsevier
Introduction Obesity is frequently a comorbidity of type 2 diabetes. Even modest weight loss
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …
Anti-diabetic drugs and weight loss in patients with type 2 diabetes.
E Lazzaroni, B Nasr, C Loretelli, I Pastore… - Pharmacological …, 2021 - europepmc.org
Results Our results suggested that anti-diabetic drugs can be stratified into 3 groups based
on their efficacy in weight loss: metformin, acarbose, empagliflozin and exenatide resulted in …
on their efficacy in weight loss: metformin, acarbose, empagliflozin and exenatide resulted in …
[引用][C] Anti-diabetic drugs and weight loss in patients with type 2 diabetes
E Lazzaroni, MB Nasr, C Loretelli, I Pastore… - Pharmacological …, 2021 - cir.nii.ac.jp